Adapalene gel 0.1% is better tolerated than tretinoin gel 0.025% among healthy volunteers of various ethnic origins
Background: The efficacious acne treatment adapalene gel 0.1% is significantly less irritating than tretinoin of various concentrations and formulations, according to several clinical studies conducted predominantly in Caucasian patients. Objectives: To confirm the lower irritation potential of adap...
Saved in:
Published in: | The Journal of dermatological treatment Vol. 20; no. 5; pp. 282 - 288 |
---|---|
Main Authors: | , , , , |
Format: | Journal Article |
Language: | English |
Published: |
Oslo
Informa UK Ltd
2009
Taylor & Francis |
Subjects: | |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Abstract | Background: The efficacious acne treatment adapalene gel 0.1% is significantly less irritating than tretinoin of various concentrations and formulations, according to several clinical studies conducted predominantly in Caucasian patients. Objectives: To confirm the lower irritation potential of adapalene gel 0.1% compared to tretinoin gel 0.025% among volunteers of various ethnic origins and to explore the difference in the irritant susceptibility among ethnic groups. Methods: The study was a single-centre, randomized, investigator-masked and intra-individual comparison. Healthy volunteers applied adapalene and tretinoin daily to the face for 21 days and to the forearms for 4 days, and were then evaluated for the level of irritation. Results: The irritation potential of adapalene gel 0.1% was significantly lower than that of tretinoin gel 0.025% in all tolerability assessments, irrespective of the volunteers' ethnic origins. The between-treatment differences were similar among various ethnic groups. Statistically significant but small inter-ethnicity differences were observed in the evaluation of facial signs, with Caucasians being less susceptible than Chinese, Asian Indians and Malays. Conclusion: Adapalene gel 0.1% was significantly better tolerated than tretinoin gel 0.025% among various ethnic groups. The patients' ethnic origins had no impact on the difference between adapalene and tretinoin treatments in terms of tolerability. |
---|---|
AbstractList | Background: The efficacious acne treatment adapalene gel 0.1% is significantly less irritating than tretinoin of various concentrations and formulations, according to several clinical studies conducted predominantly in Caucasian patients. Objectives: To confirm the lower irritation potential of adapalene gel 0.1% compared to tretinoin gel 0.025% among volunteers of various ethnic origins and to explore the difference in the irritant susceptibility among ethnic groups. Methods: The study was a single-centre, randomized, investigator-masked and intra-individual comparison. Healthy volunteers applied adapalene and tretinoin daily to the face for 21 days and to the forearms for 4 days, and were then evaluated for the level of irritation. Results: The irritation potential of adapalene gel 0.1% was significantly lower than that of tretinoin gel 0.025% in all tolerability assessments, irrespective of the volunteers' ethnic origins. The between-treatment differences were similar among various ethnic groups. Statistically significant but small inter-ethnicity differences were observed in the evaluation of facial signs, with Caucasians being less susceptible than Chinese, Asian Indians and Malays. Conclusion: Adapalene gel 0.1% was significantly better tolerated than tretinoin gel 0.025% among various ethnic groups. The patients' ethnic origins had no impact on the difference between adapalene and tretinoin treatments in terms of tolerability. BACKGROUNDThe efficacious acne treatment adapalene gel 0.1% is significantly less irritating than tretinoin of various concentrations and formulations, according to several clinical studies conducted predominantly in Caucasian patients.OBJECTIVESTo confirm the lower irritation potential of adapalene gel 0.1% compared to tretinoin gel 0.025% among volunteers of various ethnic origins and to explore the difference in the irritant susceptibility among ethnic groups.METHODSThe study was a single-centre, randomized, investigator-masked and intra-individual comparison. Healthy volunteers applied adapalene and tretinoin daily to the face for 21 days and to the forearms for 4 days, and were then evaluated for the level of irritation.RESULTSThe irritation potential of adapalene gel 0.1% was significantly lower than that of tretinoin gel 0.025% in all tolerability assessments, irrespective of the volunteers' ethnic origins. The between-treatment differences were similar among various ethnic groups. Statistically significant but small inter-ethnicity differences were observed in the evaluation of facial signs, with Caucasians being less susceptible than Chinese, Asian Indians and Malays.CONCLUSIONAdapalene gel 0.1% was significantly better tolerated than tretinoin gel 0.025% among various ethnic groups. The patients' ethnic origins had no impact on the difference between adapalene and tretinoin treatments in terms of tolerability. The efficacious acne treatment adapalene gel 0.1% is significantly less irritating than tretinoin of various concentrations and formulations, according to several clinical studies conducted predominantly in Caucasian patients. To confirm the lower irritation potential of adapalene gel 0.1% compared to tretinoin gel 0.025% among volunteers of various ethnic origins and to explore the difference in the irritant susceptibility among ethnic groups. The study was a single-centre, randomized, investigator-masked and intra-individual comparison. Healthy volunteers applied adapalene and tretinoin daily to the face for 21 days and to the forearms for 4 days, and were then evaluated for the level of irritation. The irritation potential of adapalene gel 0.1% was significantly lower than that of tretinoin gel 0.025% in all tolerability assessments, irrespective of the volunteers' ethnic origins. The between-treatment differences were similar among various ethnic groups. Statistically significant but small inter-ethnicity differences were observed in the evaluation of facial signs, with Caucasians being less susceptible than Chinese, Asian Indians and Malays. Adapalene gel 0.1% was significantly better tolerated than tretinoin gel 0.025% among various ethnic groups. The patients' ethnic origins had no impact on the difference between adapalene and tretinoin treatments in terms of tolerability. |
Author | Soto, Pascale Tang, Mark B.Y. Leok Goh, Chee Kaoukhov, Alexandre Briantais, Philippe |
Author_xml | – sequence: 1 givenname: Chee surname: Leok Goh fullname: Leok Goh, Chee email: clgoh@nsc.gov.sg organization: 1National Skin Centre, Singapore – sequence: 2 givenname: Mark B.Y. surname: Tang fullname: Tang, Mark B.Y. email: clgoh@nsc.gov.sg organization: 1National Skin Centre, Singapore – sequence: 3 givenname: Philippe surname: Briantais fullname: Briantais, Philippe email: clgoh@nsc.gov.sg organization: 1National Skin Centre, Singapore – sequence: 4 givenname: Alexandre surname: Kaoukhov fullname: Kaoukhov, Alexandre email: clgoh@nsc.gov.sg organization: 1National Skin Centre, Singapore – sequence: 5 givenname: Pascale surname: Soto fullname: Soto, Pascale email: clgoh@nsc.gov.sg organization: 1National Skin Centre, Singapore |
BackLink | http://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=21991024$$DView record in Pascal Francis https://www.ncbi.nlm.nih.gov/pubmed/19634042$$D View this record in MEDLINE/PubMed |
BookMark | eNp9kU9rFDEYh4NU7Lb6AbxILktPo_kzSSbopZSqhYIXPQ_ZmTe7KZlkTTKV_fZm2VGRQk-B5Hl-vO8vF-gsxAAIvaXkPSUd-UC0aKXkRBOmJKeyfYFWtFW0oUrwM7Q6vjcVaM_RRc4PhFAuSfcKnVNdL0nLVihfj2ZvPATAW_C4Bq-xy3gDpUDCJXpIpsCIy84EXBIUF6ILC0uYWGMzxbDFOzC-7A74Mfo5FICUcbT40SQX54yh7IIbcExu60J-jV5a4zO8Wc5L9OPz7febr839ty93N9f3zdByURo1sFZbqa0iVjKhWDdKRixnincb3YGWwJSWQoxWUSGlJdWQTFNOxCg6zS_R1Sl3n-LPGXLpJ5cH8N4EqFP1inPBdNeKStITOaSYcwLb75ObTDr0lPTHqvsnVVfn3ZI-byYY_xlLtxVYL4DJg_E2mTC4_JdjVGtK2DHo04lzwcY0mV8x-bEv5uBj-iPx5-b4-J9--onBJOgf4pxCbfiZLX4DQ-mqvg |
CitedBy_id | crossref_primary_10_1111_dth_12574 crossref_primary_10_1111_cod_13292 crossref_primary_10_4103_0974_2077_184043 crossref_primary_10_1007_s13555_022_00788_w crossref_primary_10_1159_000444682 crossref_primary_10_1007_s13555_023_00943_x crossref_primary_10_1080_14656566_2021_1990263 crossref_primary_10_1111_jocd_15662 crossref_primary_10_1093_ced_llad371 crossref_primary_10_1111_jocd_12031 crossref_primary_10_1177_1203475415591117 crossref_primary_10_1007_s13770_012_1088_z crossref_primary_10_3109_09546634_2012_661037 crossref_primary_10_1111_1346_8138_14314 |
Cites_doi | 10.1016/S0733-8635(03)00081-0 10.1046/j.1365-2133.1998.1390s2023.x 10.1046/j.1365-2133.1998.1390s2017.x 10.1016/S0190-9622(97)70051-3 10.1016/S0190-9622(97)70056-2 10.1034/j.1600-0536.2001.045002075.x 10.1111/j.1600-0536.1996.tb02141.x 10.1111/1523-1747.ep12323445 10.1111/j.1600-0536.1993.tb03534.x 10.1046/j.1365-2133.1998.1390s2048.x 10.1111/j.1365-2133.1993.tb03163.x 10.1046/j.1365-2133.1998.1390s2034.x 10.1067/mjd.2002.120791 10.1016/S0190-9622(97)70054-9 10.1046/j.1365-2133.1998.1390s2026.x 10.1067/mjd.2002.120790 10.1111/j.1600-0536.1998.tb05658.x 10.1111/j.1396-0296.2004.04019.x 10.1046/j.1365-2133.1998.1390s2041.x 10.1111/j.1600-0536.1999.tb06229.x |
ContentType | Journal Article |
Copyright | 2009 Informa UK Ltd All rights reserved: reproduction in whole or part not permitted 2009 2009 INIST-CNRS |
Copyright_xml | – notice: 2009 Informa UK Ltd All rights reserved: reproduction in whole or part not permitted 2009 – notice: 2009 INIST-CNRS |
DBID | IQODW CGR CUY CVF ECM EIF NPM AAYXX CITATION 7X8 |
DOI | 10.1080/09546630902763164 |
DatabaseName | Pascal-Francis Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed CrossRef MEDLINE - Academic |
DatabaseTitle | MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) CrossRef MEDLINE - Academic |
DatabaseTitleList | MEDLINE - Academic MEDLINE |
Database_xml | – sequence: 1 dbid: ECM name: MEDLINE url: https://search.ebscohost.com/login.aspx?direct=true&db=cmedm&site=ehost-live sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
EISSN | 1471-1753 |
EndPage | 288 |
ExternalDocumentID | 10_1080_09546630902763164 19634042 21991024 376486 |
Genre | Original Article Randomized Controlled Trial Research Support, Non-U.S. Gov't Journal Article |
GroupedDBID | --- 00X 03L 0BK 0R~ 0YH 29K 36B 4.4 53G 5GY 5VS AAJNR AALIY AALUX AAMIU AAPUL AAPXX AAQRR ABBKH ABDBF ABEIZ ABLKL ABPTK ABUPF ABWCV ABZEW ACENM ACFUF ACGEJ ACGFS ACKZS ACLSK ADCVX ADFCX ADFOM ADFZZ ADRBQ ADXPE AECIN AEIIZ AENEX AEOZL AEYQI AFKVX AFLEI AFWLO AGDLA AGFJD AGRBW AIJEM AIRBT AJVHN AJWEG AKBVH ALIIL ALMA_UNASSIGNED_HOLDINGS ALQZU AMDAE AWYRJ BABNJ BLEHA BOHLJ BRMBE CAG CCCUG COF CS3 CYYVM CZDIS D-I DKSSO DRXRE DU5 DWTOO EAP EBC EBD EBS EJD EMB EMK EMOBN EPL ESX F5P GROUPED_DOAJ H13 HZ~ JENTW KRBQP KSSTO KWAYT KYCEM LJTGL M44 M4Z O9- P2P QQXMO RNANH RVRKI SV3 TFDNU TFL TFW TUS UEQFS V1S ~1N ABXYU IQODW AAORF ABJNI ABLIJ AGYJP ALYBC CGR CUY CVF ECM EIF NPM NUSFT TBQAZ TDBHL TERGH TUROJ AAYXX CITATION 7X8 |
ID | FETCH-LOGICAL-c435t-7c249f69f70f625728d620f32738b98e96e279655df71566f07c26291305d5893 |
ISSN | 0954-6634 |
IngestDate | Fri Oct 25 01:54:12 EDT 2024 Fri Nov 22 00:17:21 EST 2024 Tue Oct 15 23:38:51 EDT 2024 Sun Oct 22 16:04:13 EDT 2023 Tue Jun 13 19:30:20 EDT 2023 Wed Jun 21 01:44:02 EDT 2023 |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 5 |
Keywords | Antineoplastic agent Human Skin disease Healthy subject Adapalene Toxicity Treatment efficiency irritation potential Retinoid Ethnic group Colloidal gel ethnic groups Secondary effect Antiacneic agent Comparative study Irritation Tretinoin |
Language | English |
License | CC BY 4.0 |
LinkModel | OpenURL |
MergedId | FETCHMERGED-LOGICAL-c435t-7c249f69f70f625728d620f32738b98e96e279655df71566f07c26291305d5893 |
Notes | ObjectType-Article-2 SourceType-Scholarly Journals-1 ObjectType-News-1 ObjectType-Feature-3 content type line 23 |
PMID | 19634042 |
PQID | 733529845 |
PQPubID | 23479 |
PageCount | 7 |
ParticipantIDs | proquest_miscellaneous_733529845 pubmed_primary_19634042 pascalfrancis_primary_21991024 crossref_primary_10_1080_09546630902763164 informahealthcare_journals_10_1080_09546630902763164 informaworld_taylorfrancis_310_1080_09546630902763164 |
PublicationCentury | 2000 |
PublicationDate | 20090000 1/1/2009 2009 2009-00-00 2009-01-01 20090101 |
PublicationDateYYYYMMDD | 2009-01-01 |
PublicationDate_xml | – year: 2009 text: 20090000 |
PublicationDecade | 2000 |
PublicationPlace | Oslo |
PublicationPlace_xml | – name: Oslo – name: England |
PublicationTitle | The Journal of dermatological treatment |
PublicationTitleAlternate | J Dermatolog Treat |
PublicationYear | 2009 |
Publisher | Informa UK Ltd Taylor & Francis |
Publisher_xml | – name: Informa UK Ltd – name: Taylor & Francis |
References | Dunlap FE (CIT0011) 1998; 139 Kang S (CIT0006) 1995; 105 Ellis CN (CIT0014) 1998; 139 Cunliffe WJ (CIT0015) 1998; 139 Grosshans E (CIT0012) 1998; 139 Judge MR (CIT0021) 1996; 34 Robinson MK (CIT0018) 1999; 41 Verschoore M (CIT0007) 1993; 11 CIT0019 Taylor SC (CIT0003) 2002; 46 Halder RM (CIT0001) 1983; 32 Cunliffe WJ (CIT0010) 1997; 36 CIT0023 CIT0022 Cunliffe WJ (CIT0016) 2002; 12 Goh CL (CIT0002) 1994; 11 Dunlap FE (CIT0017) 1998; 139 Basketter DA (CIT0024) 1993; 29 Verschoore M (CIT0008) 1997; 36 CIT0025 Richards GM (CIT0020) 2003; 21 CIT0004 Callender VD (CIT0005) 2005; 76 CIT0009 Galvin SA (CIT0013) 1998; 139 |
References_xml | – volume: 21 start-page: 595 year: 2003 ident: CIT0020 publication-title: Dermatol Clin. doi: 10.1016/S0733-8635(03)00081-0 contributor: fullname: Richards GM – volume: 76 start-page: 19 year: 2005 ident: CIT0005 publication-title: Cutis. contributor: fullname: Callender VD – volume: 139 start-page: 23 issue: 52 year: 1998 ident: CIT0017 publication-title: Br J Dermatol. doi: 10.1046/j.1365-2133.1998.1390s2023.x contributor: fullname: Dunlap FE – volume: 139 start-page: 17 issue: 52 year: 1998 ident: CIT0011 publication-title: Br J Dermatol. doi: 10.1046/j.1365-2133.1998.1390s2017.x contributor: fullname: Dunlap FE – volume: 36 start-page: S104 issue: 6 year: 1997 ident: CIT0008 publication-title: J Am Acad Dermatol. doi: 10.1016/S0190-9622(97)70051-3 contributor: fullname: Verschoore M – volume: 36 start-page: S126 issue: 6 year: 1997 ident: CIT0010 publication-title: J Am Acad Dermatol. doi: 10.1016/S0190-9622(97)70056-2 contributor: fullname: Cunliffe WJ – ident: CIT0022 doi: 10.1034/j.1600-0536.2001.045002075.x – volume: 34 start-page: 115 year: 1996 ident: CIT0021 publication-title: Contact Dermatitis. doi: 10.1111/j.1600-0536.1996.tb02141.x contributor: fullname: Judge MR – volume: 105 start-page: 549 year: 1995 ident: CIT0006 publication-title: J Invest Dermatol. doi: 10.1111/1523-1747.ep12323445 contributor: fullname: Kang S – volume: 11 start-page: 107 year: 1993 ident: CIT0007 publication-title: Dermatol Ther. contributor: fullname: Verschoore M – volume: 11 start-page: 15 year: 1994 ident: CIT0002 publication-title: Pediatr Dermatol. contributor: fullname: Goh CL – volume: 29 start-page: 185 year: 1993 ident: CIT0024 publication-title: Contact Dermatitis. doi: 10.1111/j.1600-0536.1993.tb03534.x contributor: fullname: Basketter DA – volume: 139 start-page: 48 issue: 52 year: 1998 ident: CIT0015 publication-title: Br J Dermatol. doi: 10.1046/j.1365-2133.1998.1390s2048.x contributor: fullname: Cunliffe WJ – volume: 12 start-page: 350 year: 2002 ident: CIT0016 publication-title: Eur J Dermatol. contributor: fullname: Cunliffe WJ – ident: CIT0023 doi: 10.1111/j.1365-2133.1993.tb03163.x – volume: 139 start-page: 34 issue: 52 year: 1998 ident: CIT0013 publication-title: Br J Dermatol. doi: 10.1046/j.1365-2133.1998.1390s2034.x contributor: fullname: Galvin SA – volume: 46 start-page: S98 year: 2002 ident: CIT0003 publication-title: J Am Acad Dermatol. doi: 10.1067/mjd.2002.120791 contributor: fullname: Taylor SC – ident: CIT0009 doi: 10.1016/S0190-9622(97)70054-9 – volume: 139 start-page: 26 issue: 52 year: 1998 ident: CIT0012 publication-title: Br J Dermatol. doi: 10.1046/j.1365-2133.1998.1390s2026.x contributor: fullname: Grosshans E – ident: CIT0019 doi: 10.1067/mjd.2002.120790 – volume: 32 start-page: 388 year: 1983 ident: CIT0001 publication-title: Cutis. contributor: fullname: Halder RM – ident: CIT0025 doi: 10.1111/j.1600-0536.1998.tb05658.x – ident: CIT0004 doi: 10.1111/j.1396-0296.2004.04019.x – volume: 139 start-page: 41 issue: 52 year: 1998 ident: CIT0014 publication-title: Br J Dermatol. doi: 10.1046/j.1365-2133.1998.1390s2041.x contributor: fullname: Ellis CN – volume: 41 start-page: 65 year: 1999 ident: CIT0018 publication-title: Contact Dermatitis. doi: 10.1111/j.1600-0536.1999.tb06229.x contributor: fullname: Robinson MK |
SSID | ssj0013608 |
Score | 1.9527136 |
Snippet | Background: The efficacious acne treatment adapalene gel 0.1% is significantly less irritating than tretinoin of various concentrations and formulations,... The efficacious acne treatment adapalene gel 0.1% is significantly less irritating than tretinoin of various concentrations and formulations, according to... BACKGROUNDThe efficacious acne treatment adapalene gel 0.1% is significantly less irritating than tretinoin of various concentrations and formulations,... |
SourceID | proquest crossref pubmed pascalfrancis informaworld informahealthcare |
SourceType | Aggregation Database Index Database Publisher |
StartPage | 282 |
SubjectTerms | Adapalene Administration, Cutaneous Adolescent Adult Aged Biological and medical sciences Dermatologic Agents - administration & dosage Dermatologic Agents - adverse effects Dermatology ethnic groups Gels Humans irritation potential Medical sciences Middle Aged Naphthalenes - administration & dosage Naphthalenes - adverse effects Pharmacology. Drug treatments Single-Blind Method Skin Diseases - chemically induced Skin Diseases - ethnology Skin Diseases - pathology Skin involvement in other diseases. Miscellaneous. General aspects Skin Irritancy Tests Skin, nail, hair, dermoskeleton tretinoin Tretinoin - administration & dosage Tretinoin - adverse effects Young Adult |
Title | Adapalene gel 0.1% is better tolerated than tretinoin gel 0.025% among healthy volunteers of various ethnic origins |
URI | https://www.tandfonline.com/doi/abs/10.1080/09546630902763164 https://www.ncbi.nlm.nih.gov/pubmed/19634042 https://search.proquest.com/docview/733529845 |
Volume | 20 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://sdu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1La9wwEBabDZReSvrePoIO7aXGwdZKsn3cptsGQnLpBtqT8UPqhgQ71N5A_31nLFl2NiS0hV7MYiw_NN9-MxrNg5B3YazzIC6EHxUi8LkOE-DBEsiwZHOR5JInXTufo6_R6bf405IvJ5O-ls5w7r9KGs6BrDFz9i-k7W4KJ-A3yByOIHU4_pHcFyWoP1AlyvuhLj0gq_dMYNfyvMvbAVPzEssoKwybhL92i0mMVX1e2asDbFMkbAsikyP5y0MGg_nHVF8wLa9hdY1xs6pdY_Mc01mrGRu5Q7pZZ-iWSP6tI1kX2j7EAtUX3pfa7PWslUPayrqyMZ3I-3jw_WBwHQCm28xURzAeoSs36jirNxfr-nqUvWPje3vfxsCdfS7W2fEousl4LbkPRpLxQSjD2aBffSw4OiZ1FozAK8YMbXodWWXPTE_BW3rEBl7C0-BhGLoKNBxKPihNF8oY9jVWt6_dIbsMyI9Nye7icHl6Muxtya5PovuUfq8dK75v3-SGtbRna-muXWTgVn1dDOzNGhClNk1Z7l41ddbTao88smigC4PXx2SiqifkwYkN7HhKGgdbCkCkCFt63lADWupASxG01IHWXougpR1kqYUsHSBLa00tZKmBLLWQfUbOPi9Xh0e-7QfiF2DUt0AnjCdaJjoKNCzbIxaXkgV6jtlleRKrRCqYcSlEqSN0S-gARkiWgJkmSgGG-XMyrepKvSS0kDKbKyHzLBK8KHnONMszxnWpg0CFfEY-9POeXpmyL-mdkp4RfksyqaWE5r5hYiy8tO1cdFZ06fyecfs3pOxekGEYI9jcM0J7saegLHAHMKsUTHMaYYZlEnMxIy8MHIavA03MQYO_-rePeU0emn1WdE6-IdP250a9JTtNudm3-P8NYujiMg |
link.rule.ids | 315,782,786,4028,27932,27933,27934,59868,60657,61275,61456 |
linkProvider | Taylor & Francis |
linkToHtml | http://sdu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1Lb9QwEB61Wwm40FJeS2mZA70gRWS9thNfKq3KVlvR3QtF4hYlsU1XqhJEskj9953Joy9KD_SeiWyPZ-Ybzwvg4yj2WRjnKohyFQbSjwzpQUvK0IqxMpmWphnnM_sWLX7EX6bcJuegr4XhtEr2oX3bKKLR1Szc_Bjdp8R9JlggyVJySiGJBwH-ddjgPuPxADYmh9PF_DqOoJuZdEwQEIXs45r3_eSWZdrq-paeXWVh3ellykmUaUXn6NsBGP9GqI2lOtp87B634HmHUXHSXqoXsOaKbXgy76LwL6GaWDKxZK4c_nTnSL_ax2WFWVMZhHV5zo2anUV-lceayySLcll03xL62cdmxBG2u75A1pDEXwKiWHr8Q957uarQ1WfFMsd2clf1Cr4fTU8PZ0E3vCHICYHVxHty7Lw2Pgo9-ViRiK0WoR9zKVBmYme0E5HRSlkfsQ_pQ6LQwpBNVVYRinoNg6Is3FvAXOt07JTO0kjJ3MpMeJGlQnrrw9CN5BA-9YxLfrU9OpJR3_r07jEOQf7F2qST2-ohMnWT-0ndvKd0vE_GD9Dt3bomVwsUnHNGAGkI2N-bhCSbwzVp4eiYk4jL4Uws1RDetPfpenekNiWp23f_uaoP8HR2Oj9JTo4XX3fgWRsh42el9zCof6_cLqxXdrXXSdMlEpkXrg |
linkToPdf | http://sdu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1LT9wwEB4VkFAvhb6XAp1DuVSKmvXaTnzgsIJdgSirSm2l3qIktmEllKAmi8S_ZyYPKBQ4wD0T2R7PzDeeF8CXYeyzMM5VEOUqDKQfGtKDlpShFSNlMi1NM87n4Gc0-xPvT7hNzm5fC8NplexD-7ZRRKOrWbjPre8z4r4RKpBkKDmjkKSD8P4SrBAOV-R7rYz3JrPjmzCCbkbSMUFAFLIPa973k1uGab1rW3p6nYR1p5Up51CmFR2jb-dfPAxQG0M1XXvmFtfhVYdQcdxeqdfwwhVvYPW4i8G_hWpsycCSsXJ44s6QfrWD8wqzpi4I6_KM2zQ7i_wmjzUXSRblvOi-Jeyzg82AI2w3fYmsH4m7BEOx9HhBvnu5qNDVp8U8x3ZuV_UOfk8nv_YOgm50Q5AT_qqJ8-TWeW18FHrysCIRWy1CP-JCoMzEzmgnIqOVsj5iD9KHRKGFIYuqrCIM9R6Wi7JwHwFzrdORUzpLIyVzKzPhRZYK6a0PQzeUA_ja8y05bzt0JMO-8endYxyA_I-zSSe11WNk6l_mJ3XzmtKxPhk9Qrd965ZcL1BwxhnBowFgf20SkmsO1qSFo2NOIi6GM7FUA_jQXqeb3ZHSlKRsN564qs-w-mN_mnw_nB19gpdteIzflDZhuf67cFuwVNnFdidLV32QFlI |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Adapalene+gel+0.1%25+is+better+tolerated+than+tretinoin+gel+0.025%25+among+healthy+volunteers+of+various+ethnic+origins&rft.jtitle=The+Journal+of+dermatological+treatment&rft.au=Leok+Goh%2C+Chee&rft.au=Tang%2C+Mark+B.Y.&rft.au=Briantais%2C+Philippe&rft.au=Kaoukhov%2C+Alexandre&rft.date=2009&rft.pub=Informa+UK+Ltd&rft.issn=0954-6634&rft.eissn=1471-1753&rft.volume=20&rft.issue=5&rft.spage=282&rft.epage=288&rft_id=info:doi/10.1080%2F09546630902763164&rft.externalDocID=10_1080_09546630902763164 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0954-6634&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0954-6634&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0954-6634&client=summon |